Montalescot G - Search Results

1

Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.

Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G. Dumaine R, et al. Among authors: montalescot g. Arch Intern Med. 2007 Dec 10;167(22):2423-30. doi: 10.1001/archinte.167.22.2423. Arch Intern Med. 2007. PMID: 18071163 Review.

2

Fibrinogen as a risk factor for coronary heart disease.

Montalescot G, Collet JP, Choussat R, Thomas D. Montalescot G, et al. Eur Heart J. 1998 Jul;19 Suppl H:H11-7. Eur Heart J. 1998. PMID: 9717059 Review.

3

Pharmacological remodeling of the thrombus architecture.

Collet JP, Montalescot G, Soria J, Mishal Z, Soria C. Collet JP, et al. Among authors: montalescot g. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S49-53. Blood Coagul Fibrinolysis. 1999. PMID: 10070819 Review. No abstract available.

4

Low molecular weight heparins in the cardiac catheterization laboratory.

Montalescot G, Cohen M. Montalescot G, et al. J Thromb Thrombolysis. 1999 Jun;7(3):319-23. doi: 10.1023/a:1008943529597. J Thromb Thrombolysis. 1999. PMID: 10373715 Review. No abstract available.

5

[Low molecular weight heparin in unstable angina and myocardial infarction without Q wave].

Choussat R, Montalescot G. Choussat R, et al. Among authors: montalescot g. Presse Med. 1999 Jun 12;28(21):1128-34. Presse Med. 1999. PMID: 10399506 Review. French.

6

Acute myocarditis presenting as acute myocardial infarction and sudden death with complete atrioventricular block: value of antimyosin scintigraphy.

Vilain D, Collet JP, Sarda L, Choussat R, Montalescot G, Le Guludec D, Faraggi M. Vilain D, et al. Among authors: montalescot g. J Nucl Cardiol. 1999 Sep-Oct;6(5):547-8. doi: 10.1016/s1071-3581(99)90028-4. J Nucl Cardiol. 1999. PMID: 10548151 No abstract available.

7

[Antithrombotics and interventional cardiology].

Collet JP, Montalescot G. Collet JP, et al. Among authors: montalescot g. Arch Mal Coeur Vaiss. 1999 Nov;92(11 Suppl):1667-79. Arch Mal Coeur Vaiss. 1999. PMID: 10598250 Review. French.

8

Low molecular weight heparin after mechanical heart valve replacement.

Montalescot G, Polle V, Collet JP, Leprince P, Bellanger A, Gandjbakhch I, Thomas D. Montalescot G, et al. Circulation. 2000 Mar 14;101(10):1083-6. doi: 10.1161/01.cir.101.10.1083. Circulation. 2000. PMID: 10715251 Clinical Trial.

9

Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Collet JP, et al. Among authors: montalescot g. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1354-61. doi: 10.1161/01.atv.20.5.1354. Arterioscler Thromb Vasc Biol. 2000. PMID: 10807754

10

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.

Montalescot G, Collet JP, Lison L, Choussat R, Ankri A, Vicaut E, Perlemuter K, Philippe F, Drobinski G, Thomas D. Montalescot G, et al. J Am Coll Cardiol. 2000 Jul;36(1):110-4. doi: 10.1016/s0735-1097(00)00695-1. J Am Coll Cardiol. 2000. PMID: 10898421 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

811 results

Search Page

Filters